Navigating the Market for GLP-1 Medications in Germany: A Comprehensive GuideRecently, the medical landscape for treating type 2 diabetes and obesity has been changed by a class of drugs referred to as GLP-1 receptor agonists (Glucagon-like peptide-1). In Germany, the demand for these medications-- most significantly brand names like Ozempic,